The 49th Union World Conference on Lung Health is pleased to announce TBScience2018, an official pre-conference event entirely devoted to basic and translational TB research.
Participants attending TBScience should collect their badge from The Hague Marriott Hotel.Download the programme here
For the first time, TBScience2018 will bring together scientists from microbiology, immunology, molecular biology, pharmacology, epidemiology and mathematical modelling to present and discuss recent findings on TB transmission, infection and disease. Additional focus will also be given to the development of better vaccines, new drugs and efficient but effective diagnostics for TB, and methodological challenges to determining the burden of TB disease at the subnational level.
The pre-conference will take place from 08:30 on 23 October until midday 24 October, and held at The Hague Marriott Hotel, located just near the Union World Conference venue, the World Forum.
TBScience2018 is organised by The Union in proud partnership with the National Institutes of Health, the KNCV Tuberculosis Foundation, the Amsterdam Institute for Global Health and Development (AIGHD), TB Surveillance and Research Unit (TSRU) and the European and Developing Countries Clinical Trials Partnership (EDCTP) .
TBScience2018 features an extensive offering of sessions and events. The programme is available through the Union World Conference online programme, which is available as a fully searchable online agenda, allowing participants to plan their schedule and highlight sessions of the greatest interest to them.Search the online programme
Registration for TBScience2018 is closed.
Submissions to TBScience2018 are now closed.
All aspects of TB prevention, diagnosis and treatment basic science research, particularly new, innovative and significant findings are welcomed for submission at the first TBScience meeting.
All submitted abstracts will be scored by multiple peer reviewers, and the highest scoring abstracts will be selected for presentation. Persons submitting abstracts will be notified of acceptance or rejection of their abstract by 27 August. Note that decisions of the abstract review committee are final and cannot be appealed.
A small number of travel grants are available for accepted abstracts presenters who require funding to attend the conference. If you intend to request support, an indication of your desire and rationale for consideration for a travel grant must be submitted online together with the abstract. The reviewing committee will be blinded to the request for travel funds.
The views expressed in written conference materials or publications and by speakers and moderators at HHS-sponsored conferences do not necessarily reflect the official policies of the Department of Health and Human Services (HHS), nor does mention of trade names, commercial practices, or organisations imply endorsement by the U.S. Government.